A detailed history of Urban Wealth Management, LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Urban Wealth Management, LLC holds 2,472 shares of LTRN stock, worth $9,344. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,472
Holding current value
$9,344
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$4.82 - $7.45 $11,915 - $18,416
2,472 New
2,472 $14,000

Others Institutions Holding LTRN

About Lantern Pharma Inc.


  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $40.9M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Urban Wealth Management, LLC Portfolio

Follow Urban Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Urban Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Urban Wealth Management, LLC with notifications on news.